Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Celsius Holdings, Inc.    CELH

SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Celsius Holdings, Inc. : to Release Fourth Quarter 2016 Financial Results on Thursday, March 30, 2017

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/21/2017 | 01:31pm CET

BOCA RATON, FL / ACCESSWIRE / March 21, 2017 / Celsius Holdings, Inc. (OTCQB: CELH), the makers of CELSIUS®, a leading fitness drink, today announced that it will release financial results for the fourth quarter ended December 31, 2016 on Thursday, March 30, 2017 after the market close. Management will then host a conference call that same day at 4:30 pm Eastern Time to discuss the results with the investment community.

To participate in the conference call, please call one of the following telephone numbers at least 10 minutes before the start of the call:

- US: 877-709-8150
- International: ­201-689-8354

An audio replay of the call will be available on the Company's website at http://celsius.com/press-releases/.

About Celsius Holdings, Inc.

Celsius Holdings, Inc. (CELH), founded in April, 2004, is a global company, with a proprietary, clinically proven formula for flagship brand CELSIUS®. Celsius Holdings, Inc., has a corporate mission to become the global leader of a branded portfolio which is proprietary, clinically proven or patented in its category, and offers significant health benefits.

CELSIUS®' original line comes in seven delicious sparkling and non-carbonated flavors, and in powder stick packets which can be mixed with water. CELSIUS® has no preservatives, no aspartame, no high fructose corn syrup, is non-gmo, with no artificial flavors or colors, and is very low in sodium. The CELSIUS® line of products is kosher and vegan certified, soy, gluten, and sugar free. CELSIUS®' new natural line, is also available in six refreshing flavors: 3 sparkling - grapefruit, cucumber lime, orange pomegranate and 3 non-carbonated - pineapple coconut, watermelon berry and strawberries & cream.

The first university study of the science underlying CELSIUS® products was conducted in 2005, and additional studies from the University of Oklahoma were conducted over the next five years. All studies were published in peer-reviewed journals and validate the unique benefits CELSIUS® provides to the consumer.

For more information, please visit www.celsius.com.

Investor Relations:

Hayden IR
Brett Maas
(646) 536-7331
brett@haydenir.com

or

Cameron Donahue
(651) 653-1854
cameron@haydenir.com

SOURCE: Celsius Holdings, Inc.


© Accesswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CELSIUS HOLDINGS, INC.
03/21 CELSIUS HOLDINGS, INC. : to Release Fourth Quarter 2016 Financial Results on Thu..
03/17 CELSIUS : Boca Raton energy drink maker Celsius raises another $15 million
03/14 CELSIUS HOLDINGS, INC. (OTCMKTS : CELH) Files An 8-K Unregistered Sales of Equit..
03/14 CELSIUS HOLDINGS, INC. : Unregistered Sale of Equity Securities, Financial State..
02/28 CELSIUS HOLDINGS, INC. : CELSIUS(R) Launches Line Extension for Natural Channel
02/27 CELSIUS HOLDINGS, INC. (OTCMKTS : CELH) Files An 8-K Departure of Directors or C..
02/27 CELSIUS HOLDINGS, INC. : Change in Directors or Principal Officers, Financial St..
02/24 CELSIUS HOLDINGS, INC. : CELSIUS Holdings Inc. Announces Retirement of President..
02/01 CELSIUS HOLDINGS, INC. : Unregistered Sale of Equity Securities, Financial State..
01/19 INSIDER TRADING ACTIVITY CELSIUS HOL : CELH) – Major Shareholder Bought 10..
More news
Sector news : Pharmaceuticals - NEC
03:14a YouTube's bid to grab TV dollars imperiled by advertiser revolt
03/23DJPRESS RELEASE : FDA Grants Approval for -3-
03/23DJPRESS RELEASE : FDA Grants Approval for -2-
03/23DJPRESS RELEASE : FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immuno..
03/23 TEVA PHARMACEUTICAL INDUSTRIES : Pharm says media reports of up to 6,000 layoffs..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/08 Unprecedented Insider Buying In The Shares Of Celsius Holdings Begs The Quest..
02/12 INSIDERINSIGHTS.COM DAILY ROUND UP 2 : Ty, arnc, celh
02/01 INSIDERINSIGHTS.COM DAILY ROUND UP 1 : Celh, opk, glv, agc
01/19 INSIDERINSIGHTS.COM DAILY ROUND UP 1 : Celh, tpre, virt, nick
01/18 Trump Might Keep These Stocks Afloat... Until Spring
Advertisement
Managers
NameTitle
John Fieldly President, Chief Executive & Financial Officer
William H. Milmoe Co-Chairman
Tim Leissner Co-Chairman
Thomas E. Lynch Independent Director
Kevin Harrington Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CELSIUS HOLDINGS, INC.0
JOHNSON & JOHNSON9.28%342 277
ROCHE HOLDING LTD.7.52%217 164
PFIZER INC.5.57%205 273
NOVARTIS AG-0.94%194 072
MERCK & CO., INC.7.49%174 344
More Results